Stay updated on Influenza Prevention with Self-Amplifying RNA Clinical Trial
Sign up to get notified when there's something new on the Influenza Prevention with Self-Amplifying RNA Clinical Trial page.

Latest updates to the Influenza Prevention with Self-Amplifying RNA Clinical Trial page
- CheckyesterdayChange DetectedThe site footer’s software revision number changed from v3.8.0 to v3.8.1.SummaryDifference0.0%

- Check8 days agoChange DetectedThe ClinicalTrials.gov page now displays Pfizer’s Phase 1 influenza saRNA vaccine study record, including its eligibility criteria, locations, design, and outcomes, instead of a 403 error screen.SummaryDifference89%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.2 to v3.8.0, while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check29 days agoChange DetectedA site-wide NIH banner announces an upcoming website transition and a change in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check36 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check43 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1; the page remains a 403 error page without study details.SummaryDifference0.2%

Stay in the know with updates to Influenza Prevention with Self-Amplifying RNA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Influenza Prevention with Self-Amplifying RNA Clinical Trial page.